Cellular and molecular determinants of all-trans retinoic acid sensitivity in breast cancer: Luminal phenotype and RARα expression.
about
Lipid-sensors, enigmatic-orphan and orphan nuclear receptors as therapeutic targets in breast-cancerImpaired aldehyde dehydrogenase 1 subfamily member 2A-dependent retinoic acid signaling is related with a mesenchymal-like phenotype and an unfavorable prognosis of head and neck squamous cell carcinoma.ω-3 free fatty acids and all-trans retinoic acid synergistically induce growth inhibition of three subtypes of breast cancer cell linesAll-trans-retinoic Acid Modulates the Plasticity and Inhibits the Motility of Breast Cancer Cells: ROLE OF NOTCH1 AND TRANSFORMING GROWTH FACTOR (TGFβ).MicroRNA networks regulated by all-trans retinoic acid and Lapatinib control the growth, survival and motility of breast cancer cellsBlocking the PAH2 domain of Sin3A inhibits tumorigenesis and confers retinoid sensitivity in triple negative breast cancerRARα2 and PML-RAR similarities in the control of basal and retinoic acid induced myeloid maturation of acute myeloid leukemia cellsNetwork-guided modeling allows tumor-type independent prediction of sensitivity to all-trans-retinoic acid.Cellular retinoid binding-proteins, CRBP, CRABP, FABP5: Effects on retinoid metabolism, function and related diseases.Estradiol-Estrogen Receptor α Mediates the Expression of the CXXC5 Gene through the Estrogen Response Element-Dependent Signaling PathwayPml nuclear body disruption cooperates in APL pathogenesis and impairs DNA damage repair pathways in mice.RA and ω-3 PUFA co-treatment activates autophagy in cancer cells.A retinoic acid-dependent stroma-leukemia crosstalk promotes chronic lymphocytic leukemia progression.Synergistic antitumor activity by combining trastuzumab with retinoic acid in HER2 positive human breast cancer cells.Uncovering Cellular retinoic acid-binding protein 2 as a potential target for rheumatoid arthritis synovial hyperplasia.Traffic lights for retinoids in oncology: molecular markers of retinoid resistance and sensitivity and their use in the management of cancer differentiation therapy
P2860
Q26764743-02681F4C-F631-4A64-B4E0-F925AB8EF845Q27853287-57136F93-E343-42DC-B844-328AEB41931DQ33774367-9480A1CF-2C52-4410-8D43-488B05309FB0Q35859452-CF9D87CD-F789-4490-9DEE-2F5ECA62F602Q35955244-A38377D7-6B70-4181-B3F7-B6B9558D7076Q37536680-C8358B10-0252-4025-8A8C-BE45E8D4283EQ38758034-CC77336D-FFF6-4E2B-81FF-89F98FA820F4Q39086386-27DD6153-A6B3-4284-8116-1070BD8027AFQ39108405-31CFB0EF-2440-43DC-9158-03BE958EA390Q42116309-1B4AC4B6-E90C-4819-BD61-51E65A058190Q45974271-75C59EE5-57F2-4836-B802-AB5896A5979AQ47192015-B59CBE07-87BB-41DC-9E92-EFB17C180CE9Q55261210-D64A9A91-232C-4C1A-942C-607B70324BE4Q55317203-0220FB4C-96FD-4C1A-9F28-8D0CA6AA96E3Q55481331-CF9E4650-35FF-447F-A040-4142A35B33C3Q58544569-EA057ABE-8788-43C9-AFBA-3C541C111DF6
P2860
Cellular and molecular determinants of all-trans retinoic acid sensitivity in breast cancer: Luminal phenotype and RARα expression.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Cellular and molecular determi ...... phenotype and RARα expression.
@ast
Cellular and molecular determi ...... phenotype and RARα expression.
@en
type
label
Cellular and molecular determi ...... phenotype and RARα expression.
@ast
Cellular and molecular determi ...... phenotype and RARα expression.
@en
prefLabel
Cellular and molecular determi ...... phenotype and RARα expression.
@ast
Cellular and molecular determi ...... phenotype and RARα expression.
@en
P2093
P2860
P50
P356
P1476
Cellular and molecular determi ...... phenotype and RARα expression.
@en
P2093
Adriana Zanetti
Enrico Garattini
Floriana Centritto
Francesca Piccotti
Linda Pattini
Mami Kurosaki
Marco Bolis
Maria Monica Barzago
Mark Francis Scott
Maurizio Gianni'
P2860
P304
P356
10.15252/EMMM.201404670
P50
P577
2015-04-17T00:00:00Z